3-Benzyl(phenethyl)-2-thioxobenzo[g]quinazolines as a new class of potent α-glucosidase inhibitors: Synthesis and molecular docking study

by Al-Salahi R.; Ahmad R.; Anouar E.; Iwana Nor Azman N.I.; Marzouk M.; Abuelizz H.A.
Published in Future Medicinal Chemistry (2018)

New pyrrolopyridine-based thiazolotriazoles as diabetics inhibitors: enzymatic kinetics and in silico study

by Taha M.; Rahim F.; Hayat S.; Chigurupati S.; Khan K.M.; Imran S.; Ali Shah S.A.; Uddin N.; Felemban S.G.; Venugopal V.
Published in Future Medicinal Chemistry (2023)

Synthesis, biological and computational evaluation of benzoxazole hybrid analogs as potential anti-Alzheimer's agents

by Othman M.S.; Hussain R.; Rahim F.; Ullah H.; Khan S.; Taha M.; Fareid M.A.; Altaleb A.T.; Aboelnaga S.M.; Shah S.A.A.
Published in Future Medicinal Chemistry (2024)

Synthesis of 2,4-dihydroxyacetophenone derivatives as potent PDE-1 and -3 inhibitors: in vitro and in silico insights

by Alam A.; Gul S.; Zainab; Khan M.; Elhenawy A.A.; Islam M.S.; Ali M.; Ali Shah S.A.; Latif A.; Ahmad M.
Published in Future Medicinal Chemistry (2024)

Cu(II) complexes based on benzimidazole ligands: synthesis, characterization, DFT, molecular docking & bioactivity study

by Hamali, Muhamad Azwan; Roney, Miah; Dubey, Amit; Uddin, Md Nazim; Zulkifli, Nur Amira; Aluwi, Mohd Fadhlizil Fasihi Mohd; Musa, Maslinda; Tajuddin, Amalina Mohd; Kassim, Karimah
Published in FUTURE MEDICINAL CHEMISTRY (2024)